NEXSTIM OYJ 

$2.52
5
+$0.00+0% Wednesday 14:10

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15AugExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
-0.15
0.13
0.41
0.68
Expected EPS
0.68404519008
Actual EPS
N/A

Financials

-15.58%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
12.45MRevenue
-1.94MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Nemaura Medical
NMRD
Mkt Cap4,035
Nemaura Medical Inc. competes with Nexstim in the development of medical devices for the healthcare sector, focusing on diabetes management which overlaps with Nexstim's focus on therapeutic and diagnostic medical devices.
Neogen
NEOG
Mkt Cap2.54B
Neogen Corporation offers products for food and animal safety testing, which indirectly competes with Nexstim's focus on innovative health technologies and diagnostics.
Inogen
INGN
Mkt Cap145.96M
Inogen, Inc. provides portable oxygen concentrators for patients requiring respiratory therapy, indirectly competing with Nexstim's therapeutic devices in the broader healthcare equipment sector.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers medical technologies, services, and solutions, including neuromodulation devices that compete with Nexstim's navigated brain stimulation technology for therapeutic uses.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with Nexstim in the neuromodulation and neurostimulation device market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. focuses on pharmaceuticals for central nervous system disorders among other areas, competing with Nexstim's non-drug therapies for similar conditions.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including neurotechnology and spine products, directly competing with Nexstim's offerings in the neurostimulation and neuromodulation market.

About

Nexstim Plc, a medical technology enterprise, specializes in the creation and global distribution of non-invasive brain stimulation technologies, with operations spanning Finland, Europe, North America, and other international markets. Central to its offerings is the proprietary SmartFocus technology, featuring 3D navigation, which underpins its navigated transcranial magnetic stimulation (TMS) approach utilized for both therapeutic interventions and diagnostic assessments. The company provides two distinct systems: the NBT system, a navigated brain therapy solution designed for addressing major depression and chronic neuropathic pain, and the NBS system, a navigated brain stimulation device engineered for precise pre-surgical mapping of the brain's speech and motor cortices. Nexstim predominantly sells its NBS systems to academic institutions and teaching hospitals. Established in 2000, Nexstim Plc's corporate headquarters are located in Helsinki, Finland.
Show more...
CEO
Mikko Karvinen
Employees
44
Country
Finland

Listings

0 Comments

Share your thoughts

FAQ

What is NEXSTIM OYJ stock price today?
The current price of NXTOF is $2.52 USD — it has increased by +0% in the past 24 hours. Watch NEXSTIM OYJ stock price performance more closely on the chart.
What is NEXSTIM OYJ stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on PINK exchange NEXSTIM OYJ stocks are traded under the ticker NXTOF.
What is NEXSTIM OYJ revenue for the last year?
NEXSTIM OYJ revenue for the last year amounts to 12.45M USD.
What is NEXSTIM OYJ net income for the last year?
NXTOF net income for the last year is -1.94M USD.
How many employees does NEXSTIM OYJ have?
As of September 07, 2026, the company has 44 employees.
In which sector is NEXSTIM OYJ located?
NEXSTIM OYJ operates in the Health & Wellness sector.
When did NEXSTIM OYJ complete a stock split?
NEXSTIM OYJ has not had any recent stock splits.
Where is NEXSTIM OYJ headquartered?
NEXSTIM OYJ is headquartered in Helsinki, Finland.